Moreover, TAMs have been shown to promote the angiogenic process of HCC by producing vascular endothelial growth factors (33), enhancing cell stemness by upregulating secretion of the protein S100A9 (34, 35), and even increasing drug resistance by inducing immunosuppression (36). Here, VEGFA is linked to hepatocellular carcinoma.